
Number of publications published per year by Lawless, Matthew W.. (Source : PubMed)

Distribution of publications types for Lawless, Matthew W.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Hemochromatosis protein HFE C282Y conformational considerations.
Hepatology
2010

Histone deacetylase inhibitors target diabetes via chromatin remodeling or as chemical chaperones?
Current diabetes reviews
2009;5;3

Targeting histone deacetylases for the treatment of immune, endocrine & metabolic disorders.
Endocrine, metabolic & immune disorders drug targets
2009;9;1

Mortality in humans with pneumonia and sepsis is related to an uncompensated anti-inflammatory response to infection.
Arch. Intern. Med.
2008;168;13

Tauroursodeoxycholic acid: relieving the pathogenesis of HFE C282Y hereditary hemochromatosis.
Hepatology
2008;48;1

Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
J. Inherit. Metab. Dis.
2008;31;1
Hereditary hemochromatosis should be considered a conformational disorder.
Med. Hypotheses
2008;70;4
Tauroursodeoxycholic acid inhibits apoptosis induced by Z alpha-1 antitrypsin via inhibition of Bad.
Hepatology
2007;46;2
[ See timeline ] [ See all publications ]
means that Lawless, Matthew W. has 11 papers cited a least 11 times - methodology
Department of Clinical Medicine, Trinity Centre for Health Sciences, Dublin, Ireland.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.